You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Aarti Drugs jumps after fixing record date for buyback

Capital Market 

rose 5.01% to Rs 768.70 at 9:26 on after the company fixed 19 January 2018 as record date for of upto 2.75 lakh representing upto 1.15% stake at Rs 875 per share.

The announcement was made after market hours yesterday, 8 January 2018.

Meanwhile, the Sensex was up 38.73 points, or 0.11% to 34,391.52.

On the BSE, 25,000 were traded in the counter so far, compared with average daily volumes of 12,000 in the past two weeks. The stock had hit a high of Rs 784.80 so far during the day, which is also its 52-week high for the counter. The stock had hit a low of Rs 760.05 so far during the day. The stock hit a 52-week low of Rs 456.25 on 24 May 2017.

On a consolidated basis, Aarti Drugs' net profit rose 6.9% to Rs 23.60 crore on 1.3% growth in net sales to Rs 319.27 crore in Q2 September 2017 over Q2 September 2016.

is a company. The company has a strong presence in the anti-diarrhea, anti-inflammatory therapeutic groups. With its at and Sarigam, the company manufactures vitamins, anti-arthritis, anti-fungal, antibiotics, ACE inhibitors, besides its range in anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, January 09 2018. 09:26 IST